Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2017) | Total Docs. (3years) | Total Refs. (2017) | Total Cites (3years) |  Citable Docs. (3years) |
Cites / Doc. (2years) | Ref. / Doc. (2017) | %Female (2017) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Frontiers in Pharmacology | journal | 1.587 Q1 | 154 | 939 | 1090 | 58981 | 4637 | 1025 | 3.85 | 62.81 | 44.35 |  |
| 2 | Advances in Therapy | journal | 1.075 Q2 | 83 | 209 | 310 | 8666 | 1007 | 304 | 3.22 | 41.46 | 37.38 | |
| 3 | Cardiology | journal | 0.705 Q2 | 72 | 120 | 390 | 2910 | 489 | 291 | 1.24 | 24.25 | 30.05 | |
| 4 | Chemotherapy | journal | 0.524 Q3 | 61 | 45 | 158 | 1093 | 273 | 155 | 1.74 | 24.29 | 35.64 | |
| 5 | Vaccines | journal | 1.691 Q1 | 85 | 51 | 141 | 3816 | 745 | 137 | 5.54 | 74.82 | 43.58 | |
| 6 | Antibiotics | journal | 1.063 Q2 | 77 | 39 | 116 | 2276 | 357 | 112 | 2.84 | 58.36 | 47.03 | |
| 7 | Inflammopharmacology | journal | 0.925 Q2 | 68 | 59 | 111 | 3377 | 353 | 105 | 3.33 | 57.24 | 42.97 | |
| 8 | Drugs - Real World Outcomes | journal | 21 | 26 | 91 | 839 | 92 | 88 | 1.03 | 32.27 | 46.62 | | |
| 9 | Journal of Cardiovascular Development and Disease | journal | 32 | 22 | 70 | 1902 | 107 | 65 | 1.75 | 86.45 | 40.00 | | |
| 10 | WHO Drug Information | journal | 0.490 Q3 | 11 | 13 | 39 | 80 | 21 | 35 | 0.60 | 6.15 | 29.41 | |
| 11 | Pharma-Kritik (discontinued) | journal | 0.103 Q4 | 2 | 13 | 40 | 191 | 1 | 30 | 0.04 | 14.69 | 33.33 | |
| 12 | EJNMMI Radiopharmacy and Chemistry | journal | 28 | 16 | 13 | 484 | 32 | 11 | 2.46 | 30.25 | 39.53 | | |
| 13 | PharmacoEconomics - Open | journal | 20 | 29 | 0 | 942 | 0 | 0 | 0.00 | 32.48 | 38.18 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data